TRCT
LICN icon

Tower Research Capital (TRC)’s Lichen China LICN Stock Holding History

Tower Research Capital (TRC)’s Portfolio LICN Stock Details LICN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12
Closed -$4.43K – 5869
2024
Q3 		$4.43K Buy
+12
New +$4.62K ﹤0.01% 4547

Other funds holding LICN

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

Tower Research Capital (TRC)'s LICN Position: Q4 2024 in Review

Tower Research Capital (TRC) sold out of Lichen China (LICN) in Q4 2024, closing a stake of 12 shares — an estimated $4.43K sold.

Tower Research Capital (TRC) first reported a position in LICN in Q3 2024 and held it in 1 quarter. The position peaked at $4.43K in Q3 2024. 7 funds tracked by Wall St. Rank hold LICN as of Q4 2024.

  • Tower Research Capital (TRC) reported no remaining Lichen China position as of Q4 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 12 Lichen China shares in Q4 2024, an estimated $4.43K.
  • Tower Research Capital (TRC) first reported a position in Lichen China in Q3 2024 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s Lichen China position peaked at $4.43K in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Lichen China as of Q4 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.